» Articles » PMID: 32149334

Role of Vaspin in Porcine Ovary: Effect on Signaling Pathways and Steroid Synthesis Via GRP78 Receptor and Protein Kinase A†

Overview
Journal Biol Reprod
Date 2020 Mar 10
PMID 32149334
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Vaspin, visceral-adipose-tissue-derived serine protease inhibitor, is involved in the development of obesity, insulin resistance, inflammation, and energy metabolism. Our previous study showed vaspin expression and its regulation in the ovary; however, the role of this adipokine in ovarian cells has never been studied. Here, we studied the in vitro effect of vaspin on various kinase-signaling pathways: mitogen-activated kinase (MAP3/1), serine/threonine kinase (AKT), signal transducer and activator of transcription 3 (STAT3) protein kinase AMP (PRKAA1), protein kinase A (PKA), and on expression of nuclear factor kappa B (NFKB2) as well as on steroid synthesis by porcine ovarian cells. By using western blot, we found that vaspin (1 ng/ml), in a time-dependent manner, increased phosphorylation of MAP3/1, AKT, STAT3, PRKAA1, and PKA, while it decreased the expression of NFKB2. We observed that vaspin, in a dose-dependent manner, increased the basal steroid hormone secretion (progesterone and estradiol), mRNA and protein expression of steroid enzymes using real-time PCR and western blot, respectively, and the mRNA of gonadotropins (FSHR, LHCGR) and steroids (PGR, ESR2) receptors. The stimulatory effect of vaspin on basal steroidogenesis was reversed when ovarian cells were cultured in the presence of a PKA pharmacological inhibitor (KT5720) and when GRP78 receptor was knocked down (siRNA). However, in the presence of insulin-like growth factor type 1 and gonadotropins, vaspin reduced steroidogenesis. Thus, vaspin, by activation of various signaling pathways and stimulation of basal steroid production via GRP78 receptor and PKA, could be a new regulator of porcine ovarian function.

Citing Articles

Breast cancer shares many epidemiological, lifestyle, and local hormonal and metabolic underpinnings with endometrial and ovarian cancer: a narrative review.

Rodriguez Y, Koomson A, Perry R Transl Breast Cancer Res. 2025; 6:8.

PMID: 39980815 PMC: 11836739. DOI: 10.21037/tbcr-24-39.


New aspect on the regulation of in vitro oocyte maturation: role of the obesity, neuropeptides and adipokines.

Kurowska P, Wyroba J, Pich K, Respekta-Dlugosz N, Szkraba O, Greggio A J Assist Reprod Genet. 2024; .

PMID: 39671071 DOI: 10.1007/s10815-024-03345-w.


Spexin role in human granulosa cells physiology and PCOS: expression and negative impact on steroidogenesis and proliferation†.

Kurowska P, Dawid M, Oprocha J, Respekta N, Serra L, Estienne A Biol Reprod. 2023; 109(5):705-719.

PMID: 37658762 PMC: 10651070. DOI: 10.1093/biolre/ioad108.


The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer.

Stepien S, Olczyk P, Gola J, Komosinska-Vassev K, Mielczarek-Palacz A Cells. 2023; 12(8).

PMID: 37190027 PMC: 10136739. DOI: 10.3390/cells12081118.


Identification of new variants and candidate genes in women with familial premature ovarian insufficiency using whole-exome sequencing.

Morales R, Lledo B, Ortiz J, Lozano F, Garcia E, Bernabeu A J Assist Reprod Genet. 2022; 39(11):2595-2605.

PMID: 36208357 PMC: 9723088. DOI: 10.1007/s10815-022-02629-3.


References
1.
Peng H, Zhao X, Bi T, Yuan X, Guo J, Peng S . PM obtained from urban areas in Beijing induces apoptosis by activating nuclear factor-kappa B. Mil Med Res. 2018; 4(1):27. PMC: 5577776. DOI: 10.1186/s40779-017-0136-3. View

2.
Rak A, Gregoraszczuk E . Modulatory effect of ghrelin in prepubertal porcine ovarian follicles. J Physiol Pharmacol. 2009; 59(4):781-93. View

3.
Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A . Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A. 2005; 102(30):10610-5. PMC: 1180799. DOI: 10.1073/pnas.0504703102. View

4.
Li Q, Chen R, Moriya J, Yamakawa J, Sumino H, Kanda T . A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res. 2008; 36(4):625-9. DOI: 10.1177/147323000803600402. View

5.
Youn B, Kloting N, Kratzsch J, Lee N, Park J, Song E . Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2007; 57(2):372-7. DOI: 10.2337/db07-1045. View